Lupin Clarifies It Has Not Received US Government Letter On Drug Price Cuts

Lupin Ltd. on Friday said it has not received any letter from the US government asking it to reduce drug prices, dismissing media reports that claimed otherwise.

Several reports had said US President Donald Trump had written to 17 global pharmaceutical companies urging them to cut prices. In a filing with exchanges, Lupin clarified it had received no such communication.